On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...